1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Oncology - ASIAN PANORAMA

Oncology - ASIAN PANORAMA

  • May 2015
  • -
  • Expernova
  • -
  • 433 pages

The following Panorama contains a detailed overview of the Scientific Expertise on Oncology, in Asia.



Cancer is a pathology characterized by uncontrolled and cellular proliferation which causes the death of millions of people worldwide every year. Lifestyles, aging, population growth and rising treatment costs, are new challenges for the fight against cancer. Lifestyle (diet and smoking), exposure to carcinogens, and hereditary factors are the main causes of cancer, amongst which the most commonly diagnosed are lung, breast, and colorectal cancer.
With almost 22 million new annual cases expected in 2030, it is essential that the domain of oncology evolves and develops. The needs of patients in oncology change requiring this special branch of medical study, diagnostic and therapeutic management to reflect on new diagnostic and therapeutic approaches. Thanks to promising, innovative treatments and new therapies, we are already observing undeniable advances which have a real impact on the chances of survival.
The experts in oncology are looking toward a future focused on personalized medicine, out-patient care and successful methods of cured patients. The development of techniques for mini or non-invasive procedures and high-definition scanners dedicated to patients, are also major topics for future development.



Featuring 20 companies’ profiles such as Takeda Pharmaceutical and Daiichi Sankyo, and 25 R&D Laboratories such as the Department of Oncology of National Taiwan University Hospital, or the Department of Medicine of the University of Hong Kong, this report is ideal for anyone wanting:



- Identify R&D Partners,



- Obtain IP & Technologic Intelligence,



- Develop your R&D Partnerships,



- And also benchmark competitors.



…all on a global scale.



You will also find 40 expert’s profiles, containing their scientific works and details of their field of expertise.



These Key Innovation Leaders are in Eastern Asia (Japan, Korea, Taiwan…).





For each of them, you will receive a scientific profile updated at time of order, a selection of focused works and a presentation of their collaborative partners, as well as an in-depth explanation of why companies such as Takeda Pharmaceutical are leaders on Oncology.





A Panorama is composed of:

- A global overview of the subject (issues, distribution of sources of expertise, international networks, European projects, main standards...)

- A selection of scientific profiles of actors (research centers , companies, experts)

- A selection of targeted works (from 50 different types of scientific and technical documents from more than 250 data sources).



Here are some examples of our data sources:



Research institutes databases (NASA, MIT, Fraunhofer, ...)



Patent Databases (European Patent Office, USPTO, ...)



Thematic Databases (MedLine/PubMed, INRA, ...)



Project Databases (Cordis FP-7, FP-6, ...)



Panorama are generated and updated with the unique mapping technology developed by Expernova, which covers 52 countries. Expernova data base is constantly growing, so each Panorama updated at any given time is potentially different from the others Panorama generated at other times on the same subject.





SCOPE OF THE PANORAMA

medical oncology, radiation oncology, pharmaceutical composition, clinical trial, malignant tumor, pediatric oncology, cancer, radiation therapy, antineoplastic agent, oncological disease, oncology nursing, gynecologic oncology




Table Of Contents

Oncology - ASIAN PANORAMA
I. General Panorama


1. Innovation Opportunities

2. Global ecosystem : overview

3. Focus : calls for proposal

4. Focus : ISO / CEN Standards




II. Selection of key-profiles and innovation leaders


1. 30 RandD Labs profiles

2. 30 Companies Profiles

3. 50 Experts profiles




III. Targeted documents


1. 25 Scientific works

2. 25 Patent families




APPENDIX

- Labs Index

- Companies Index

- Experts Index

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Immune Checkpoint Drugs in Oncology: Analytical Tool

Immune Checkpoint Drugs in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Radiation Oncology Market: By Technolgy (External (IGRT, IMRT, VMAT, & Stereotactic), Brachytherapy (LDR & HDR), & Systemic Radiotherapy), Product (Cyberknife, Gammaknife, Linac, Proton Beam), & By Application & By Region-Forecast (2016-2021)

Radiation Oncology Market: By Technolgy (External (IGRT, IMRT, VMAT, & Stereotactic), Brachytherapy (LDR & HDR), & Systemic Radiotherapy), Product (Cyberknife, Gammaknife, Linac, Proton Beam), & By Application & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Radiation oncology or radiation therapy is therapy to stop cancer cells from multiplying and cancer to spread and result into fatality. Radiation oncology uses ionizing radiation to control or kill malignant ...

Anal Cancer  - Market Insights, Epidemiology and Market Forecast-2023

Anal Cancer  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Anal Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.